Case Study

Avoid Wasted Trials: One Story Of An Estimated $100M Saved

Source: Covance

Avoid Wasted Trials: One Story Of An Estimated $100M Saved

The complexity of clinical trials continues to rise. New biomarkers for safety and efficacy continue to emerge, and new types of information – like genomic profiles – have become critical to submissions for drug approval. Against this dynamic backdrop, the central challenge facing trial sponsors is the need to bring together diverse data sets, draw meaningful insights from them and act quickly to maximize return on investment.